Does the TLR4 rs4986790 AA (Asp299Asp) genotype confer greater LPS responsiveness than the G (Asp299Gly) allele?

The TLR4 rs4986790 polymorphism, which results in an aspartate-to-glycine substitution at residue 299 (Asp299Gly), is a critical determinant of the innate immune system's sensitivity to Gram-negative bacterial lipopolysaccharide (LPS).

Clinical and immunologic evidence

• Wild-type responsiveness: Individuals with the wild-type AA (Asp299Asp) genotype exhibit normal, robust TLR4-MD2 complex assembly. This allows for complete, high-level LPS responsiveness and healthy innate immune signaling.
• G allele modulation: Carrying the G (Asp299Gly) allele leads to blunted inflammatory signaling in a gene-dose-dependent manner.
• Genotypic differences: While heterozygous (AG) individuals often display intermediate or mildly blunted ex vivo cytokine release, homozygous GG individuals exhibit profound LPS hyporesponsiveness. Upon LPS challenge, peripheral blood mononuclear cells from GG homozygotes fail to produce essential pro-inflammatory cytokines, specifically tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6).

Molecular and cellular mechanisms

• Impaired adaptor recruitment: The D299G variant alters the proximal structure of the TLR4 receptor. This structural change directly impairs the recruitment of MyD88 and TRIF adapter proteins to the receptor's cytoplasmic domain.
• Disrupted downstream cascades: Because the recruitment of MyD88 and TRIF is biologically required to transduce downstream signals, this molecular disruption prevents the downstream activation of the inflammatory cascades needed to sense and respond to LPS.

Bottom line

• The TLR4 rs4986790 AA genotype is associated with significantly greater LPS responsiveness than carriage of the G allele. G allele carriers experience disrupted MyD88 and TRIF recruitment, leading to blunted inflammatory responses and reduced production of TNF-α and IL-6, a phenotype that is most pronounced in homozygous GG individuals.